CDMO Technology Domain
Advanced Formulation — Page 2
State-of-the-art dosage form engineering: polymeric sustained-release matrices, lipid-based drug delivery, enteric-coated capsules, and novel excipient selection.
33
dossiers
Transmucosal Delivery & Dosage Form Engineering
Physicochemical Challenges in Alcohol-Free Sublingual Sprays: Solutions for Enhanced Stability and Bioavailability
Formulating stable alcohol-free sublingual sprays presents significant challenges, particularly for complex blends of amino acids and lipophilic botanicals, due to issues like crystallisation, phase separation, and subsequent nozzle obstruction.
Cellular Longevity & Senolytics
BCS Class IV Senolytics: Nano-Micellar Flavonoid Delivery for Targeted Senescence Clearance
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
Intracellular Defense & IV-Alternatives
Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
Advanced BBB Permeability Solutions
Lipidic Nanoformulations for BBB Transport of Lipophilic Phytochemicals: Current Evidence and Challenges
Lipophilic phytochemicals exhibit poor systemic and brain bioavailability due to rapid metabolism, low solubility, and active efflux at the blood-brain barrier, impeding clinical translation.
Intracellular Defense & IV-Alternatives
Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Intracellular Defense & IV-Alternatives
Non-Destructive Raman Spectroscopy for PAT-Based Botanical Contaminant Detection
Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.
Precision Microbiome & Gut-Brain Axis
Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation
Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.
Cellular Longevity & Senolytics
Comparative Pharmacokinetics and Cellular Bioaccessibility of Senolytic Agents: Impact of Polymeric-Matrix Encapsulation
Orally administered senolytic compounds often suffer from poor pharmacokinetics, including low and variable bioavailability, rapid metabolism, pH-dependent dissolution, and limited cellular bioaccessibility.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.